A busy week of quarterly results delivered regulatory milestones, broker upgrades and mixed share-price moves across ASX healthcare. ... Read More The post Scott Power: Quarterly results build ...
Corify Care introduces whole-heart mapping technology, delivering a global view of cardiac Arrhythmias in a single beat: Madrid Friday, January 30, 2026, 11:00 Hrs [IST] Corify Ca ...
Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...
“For the first time, we can non-invasively see the heart as it truly behaves—globally,” said Felipe Atienza, MD, PhD, Chief Medical Officer. “This has meaningful implications for workflow, outcomes, ...
Abbott's TactiFlex Duo Ablation Catheter, Sensor Enabled, is designed with dual-energy to treat atrial fibrillation patients with the most challenging cases It can ...
Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...
Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...
ASCs are entering a new phase of growth driven by new care pathways, staffing models and site-of-care shifts. From partnerships with orthopedic walk-in clinics to CMS coverage for EP ablation, here ...
Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically navigated magnetic ablation catheter designed to perform cardiac ablation ...
THE DVLA’S full list of medical conditions that could affect your legal right to drive have been revealed. The Driver and ...
Pulsed field ablation (PFA) has rapidly emerged as a transformative technology in catheter ablation for atrial fibrillation, ...
Investing.com -- Stereotaxis (NYSE:STXS) stock surged 8.3% Tuesday after the surgical robotics company announced it received U.S. Food and Drug Administration (FDA) approval for its MAGiC Magnetic ...